Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Glioblastoma is one of the most aggressive solid tumors, with a median overall survival of 12 to 14 months and a two-year survival of 15% to 26%.

Valganciclovir Improves Survival in Patients with Glioblastoma